Literature DB >> 31111620

Muenke syndrome: Medical and surgical comorbidities and long-term management.

Chaya N Murali1, Donna M McDonald-McGinn1, Tara Lynn Wenger2, Carey McDougall1, Bridget M Stroup3, Sarah E Sheppard4, Jesse Taylor5, Scott P Bartlett5, Elizabeth J Bhoj1, Elaine H Zackai1, Avni Santani6.   

Abstract

Muenke syndrome (MIM #602849), the most common syndromic craniosynostosis, results from the recurrent pathogenic p.P250R variant in FGFR3. Affected patients exhibit wide phenotypic variability. Common features include coronal craniosynostosis, hearing loss, carpal and tarsal anomalies, and developmental/behavioral issues. Our study examined the phenotypic findings, medical management, and surgical outcomes in a cohort of 26 probands with Muenke syndrome identified at the Children's Hospital of Philadelphia. All probands had craniosynostosis; 69.7% had bicoronal synostosis only, or bicoronal and additional suture synostosis. Three male patients had autism spectrum disorder. Recurrent ear infections were the most common comorbidity, and myringotomy tube placement the most common extracranial surgical procedure. Most patients (76%) required only one fronto-orbital advancement. de novo mutations were confirmed in 33% of the families in which proband and both parents were genetically tested, while in the remaining 66% one of the parents was a mutation carrier. In affected parents, 40% had craniosynostosis, including 71% of mothers and 13% of fathers. We additionally analyzed the medical resource utilization of probands with Muenke syndrome. To our knowledge, these data represent the first comprehensive examination of long-term management in a large cohort of patients with Muenke syndrome. Our study adds valuable information regarding neuropsychiatric and medical comorbidities, and highlights findings in affected relatives.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  zzm321990FGFR3; zzm321990FGFR3-related craniosynostosis; Muenke syndrome; affected family members; reduced penetrance; variable expressivity

Year:  2019        PMID: 31111620      PMCID: PMC6959001          DOI: 10.1002/ajmg.a.61199

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  21 in total

1.  Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis.

Authors:  Andrew O M Wilkie; Jo C Byren; Jane A Hurst; Jayaratnam Jayamohan; David Johnson; Samantha J L Knight; Tracy Lester; Peter G Richards; Stephen R F Twigg; Steven A Wall
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

2.  A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.

Authors:  M Muenke; K W Gripp; D M McDonald-McGinn; K Gaudenz; L A Whitaker; S P Bartlett; R I Markowitz; N H Robin; N Nwokoro; J J Mulvihill; H W Losken; J B Mulliken; A E Guttmacher; R S Wilroy; L A Clarke; G Hollway; L C Adès; E A Haan; J C Mulley; M M Cohen; G A Bellus; C A Francomano; D M Moloney; S A Wall; A O Wilkie
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  Syndrome of coronal craniosynostosis with brachydactyly and carpal/tarsal coalition due to Pro250Arg mutation in FGFR3 gene.

Authors:  J M Graham; S R Braddock; G R Mortier; R Lachman; C Van Dop; E W Jabs
Journal:  Am J Med Genet       Date:  1998-05-26

4.  Syndrome of coronal craniosynostosis, Klippel-Feil anomaly, and sprengel shoulder with and without Pro250Arg mutation in the FGFR3 gene.

Authors:  R B Lowry; E W Jabs; G E Graham; J Gerritsen; J Fleming
Journal:  Am J Med Genet       Date:  2001-11-22

5.  What's New in Syndromic Craniosynostosis Surgery?

Authors:  Jesse A Taylor; Scott P Bartlett
Journal:  Plast Reconstr Surg       Date:  2017-07       Impact factor: 4.730

6.  A patient with Muenke syndrome manifesting migrating neonatal seizures.

Authors:  Yukimune Okubo; Taro Kitamura; Mai Anzai; Wakaba Endo; Takehiko Inui; Yusuke Takezawa; Sato Suzuki-Muromoto; Takuya Miyabayashi; Noriko Togashi; Hiroshi Oba; Hirotomo Saitsu; Naomichi Matsumoto; Kazuhiro Haginoya
Journal:  Brain Dev       Date:  2017-05-24       Impact factor: 1.961

7.  Craniofacial growth in patients with FGFR3Pro250Arg mutation after fronto-orbital advancement in infancy.

Authors:  Emily B Ridgway; June K Wu; Stephen R Sullivan; Sivabalan Vasudavan; Bonnie L Padwa; Gary F Rogers; John B Mulliken
Journal:  J Craniofac Surg       Date:  2011-03       Impact factor: 1.046

8.  Expansion of the variable expression of Muenke syndrome: Hydrocephalus without craniosynostosis.

Authors:  Ariadna González-Del Angel; Bernardette Estandía-Ortega; Miguel Angel Alcántara-Ortigoza; Víctor Martínez-Cruz; Diana Judith Gutiérrez-Tinajero; Astrid Rasmussen; Claudia Sofía Gómez-González
Journal:  Am J Med Genet A       Date:  2016-08-29       Impact factor: 2.802

9.  Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes.

Authors:  G A Bellus; K Gaudenz; E H Zackai; L A Clarke; J Szabo; C A Francomano; M Muenke
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

10.  Phenotypic variability in two families of Muenke syndrome with FGFR3 mutation.

Authors:  Ankur Singh; Manisha Goyal; Somesh Kumar; Wolfram Kress; Seema Kapoor
Journal:  Indian J Pediatr       Date:  2014-04-06       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.